Preclinical Evaluation of Lipid-Based Nanosystems (Record no. 35128)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02041nam a2200133Ia 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220620s9999||||xx |||||||||||||| ||und|| |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783040000000 |
| 245 #0 - TITLE STATEMENT | |
| Title | Preclinical Evaluation of Lipid-Based Nanosystems |
| 546 ## - LANGUAGE NOTE | |
| Language note | English[eng] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | nanostructured lipid carriers (NLC)||formulation optimization||rivastigmine||quality by design (QbD)||nasal route||nose-to-brain||N-alkylisatin||liposome||urokinase plasminogen activator||PAI-2||SerpinB2||breast cancer||liposomes||target delivery nanosystem||FZD10 protein||colon cancer therapy||supersaturation||silica-lipid hybrid||spray drying||lipolysis||lipid-based formulation||fenofibrate||mesoporous silica||oral drug delivery||hyaluronic acid||drug release||light activation||stability||mobility||biocorona||dissolution enhancement||phospholipids||solid dosage forms||porous microparticles||nanoemulsion(s)||phase-behavior||DoE||D-optimal design||vegetable oils||non-ionic surfactants||efavirenz||flaxseed oil||nanostructured lipid carriers||nanocarrier||docohexaenoic acid||neuroprotection||neuroinflammation||fluconazole||Box‒Behnken design||nanotransfersome||ulcer index||zone of inhibition||rheological behavior||ex vivo permeation||nanomedicine||cancer||doxorubicin||melanoma||drug delivery||ultrasound contrast agents||phospholipid coating||ligand distribution||cholesterol||acoustic response||microbubble||lipid phase||dialysis||ammonia||intoxication||cyanocobalamin||vitamin B12||atopic dermatitis||psoriasis||transferosomes||lipid vesicles||skin topical delivery||oligonucleotide||self-emulsifying drug delivery systems||hydrophobic ion pairing||intestinal permeation enhancers||Caco-2 monolayer||clarithromycin||solid lipid nanoparticles||optimization||permeation||pharmacokinetics||follicular targeting||dexamethasone||alopecia areata||lipomers||lipid polymer hybrid nanocapsules||biodistribution||skin||ethyl cellulose||n/a |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Silva, Ana Catarina||Sousa Lobo, José Manuel |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://mdpi.com/books/pdfview/book/4039">https://mdpi.com/books/pdfview/book/4039</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | E-Books |
| Withdrawn status | Lost status | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre | Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre | 20/06/2022 | 20/06/2022 | 20/06/2022 | E-Books |